Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Platelets | 7 | 2016 | 2463 | 0.390 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2009 | 462 | 0.270 |
Why?
|
Cell-Derived Microparticles | 3 | 2012 | 160 | 0.270 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2023 | 1347 | 0.180 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2013 | 485 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8603 | 0.180 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 303 | 0.160 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2207 | 0.150 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5195 | 0.150 |
Why?
|
Exosomes | 1 | 2023 | 421 | 0.150 |
Why?
|
Mucin-1 | 1 | 2023 | 531 | 0.150 |
Why?
|
Neovascularization, Physiologic | 5 | 2016 | 1377 | 0.150 |
Why?
|
Neovascularization, Pathologic | 3 | 2016 | 2630 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1434 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2023 | 5336 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1644 | 0.100 |
Why?
|
Neurogenesis | 3 | 2013 | 865 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1926 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1892 | 0.090 |
Why?
|
Neural Stem Cells | 3 | 2013 | 898 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3948 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 11080 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2896 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13639 | 0.080 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2009 | 187 | 0.080 |
Why?
|
Dactinomycin | 1 | 2009 | 304 | 0.080 |
Why?
|
Cycloheximide | 1 | 2009 | 339 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22345 | 0.070 |
Why?
|
Sulfinic Acids | 1 | 2008 | 14 | 0.070 |
Why?
|
NF-kappa B | 1 | 2016 | 2486 | 0.070 |
Why?
|
Gelatin | 1 | 2009 | 227 | 0.070 |
Why?
|
Platelet Activation | 2 | 2012 | 645 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 17062 | 0.060 |
Why?
|
Endothelial Cells | 3 | 2008 | 3584 | 0.060 |
Why?
|
Wound Healing | 1 | 2016 | 2790 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2023 | 1364 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2016 | 592 | 0.060 |
Why?
|
Cytoplasm | 1 | 2009 | 1497 | 0.060 |
Why?
|
Regeneration | 1 | 2012 | 1517 | 0.050 |
Why?
|
Rats, Inbred SHR | 2 | 2013 | 189 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 94 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2013 | 10428 | 0.050 |
Why?
|
Genomics | 3 | 2023 | 5924 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2009 | 3089 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 414 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1651 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2021 | 318 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2021 | 68 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2013 | 11641 | 0.040 |
Why?
|
Actins | 1 | 2008 | 2056 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4136 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2454 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3000 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1151 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1250 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4423 | 0.040 |
Why?
|
Rats | 5 | 2013 | 23704 | 0.040 |
Why?
|
Animals | 11 | 2023 | 168731 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1409 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 632 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 2021 | 710 | 0.030 |
Why?
|
Phosphorylation | 1 | 2008 | 8279 | 0.030 |
Why?
|
Platelet Factor 4 | 1 | 2016 | 132 | 0.030 |
Why?
|
Mice | 6 | 2023 | 81792 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3273 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2016 | 254 | 0.030 |
Why?
|
Heparitin Sulfate | 1 | 2016 | 223 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1140 | 0.030 |
Why?
|
Thrombospondin 1 | 1 | 2016 | 256 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1752 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2129 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3850 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2016 | 606 | 0.030 |
Why?
|
Humans | 15 | 2023 | 765734 | 0.030 |
Why?
|
Injections, Intraventricular | 1 | 2013 | 227 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6109 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9511 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3605 | 0.030 |
Why?
|
Cell Survival | 2 | 2013 | 5747 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2012 | 310 | 0.020 |
Why?
|
Cattle | 2 | 2008 | 3800 | 0.020 |
Why?
|
Time Factors | 2 | 2012 | 40066 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2012 | 6203 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3504 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2006 | 3425 | 0.020 |
Why?
|
Stem Cell Niche | 1 | 2013 | 347 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2013 | 18289 | 0.020 |
Why?
|
Aorta | 2 | 2008 | 2027 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1823 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4446 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10730 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13448 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 959 | 0.020 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 122 | 0.020 |
Why?
|
Nitroprusside | 1 | 2006 | 271 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 2006 | 154 | 0.020 |
Why?
|
Proteins | 1 | 2021 | 5996 | 0.020 |
Why?
|
Disulfides | 1 | 2008 | 462 | 0.020 |
Why?
|
Brain | 1 | 2012 | 27178 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1866 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1242 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1820 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2822 | 0.010 |
Why?
|
Cell Movement | 2 | 2008 | 5192 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9299 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3595 | 0.010 |
Why?
|
Tubulin | 1 | 2008 | 692 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 2005 | 2077 | 0.010 |
Why?
|
P-Selectin | 1 | 2006 | 597 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2006 | 580 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2005 | 614 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2008 | 1178 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 1132 | 0.010 |
Why?
|
Microtubules | 1 | 2008 | 1062 | 0.010 |
Why?
|
Capillaries | 1 | 2005 | 751 | 0.010 |
Why?
|
Recovery of Function | 1 | 2012 | 2965 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2008 | 18972 | 0.010 |
Why?
|
Signal Transduction | 2 | 2016 | 23589 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12800 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2926 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9441 | 0.010 |
Why?
|
Nanostructures | 1 | 2005 | 548 | 0.010 |
Why?
|
Male | 4 | 2013 | 363585 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4391 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 2626 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2120 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6492 | 0.010 |
Why?
|
Peptides | 1 | 2006 | 4331 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9548 | 0.010 |
Why?
|
Female | 3 | 2021 | 395961 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7424 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9245 | 0.010 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_